<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00560898</url>
  </required_header>
  <id_info>
    <org_study_id>00001418</org_study_id>
    <secondary_id>00001418</secondary_id>
    <nct_id>NCT00560898</nct_id>
  </id_info>
  <brief_title>Comparison of Two Multi-Purpose Solution and Lens Material Combinations on Corneal Barrier Function</brief_title>
  <official_title>Comparison of Two Multi-Purpose Solution and Contact Lens Material Combinations on Human Corneal Barrier Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southern California College of Optometry at Marshall B. Ketchum University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Southern California College of Optometry at Marshall B. Ketchum University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to measure the relative &quot;barrier&quot; function of the top layer of&#xD;
      the cornea (called the epithelium), or the degree to which the cornea can prevent the&#xD;
      penetration of the colored dye sodium fluorescein into the eye. This is a clinical&#xD;
      investigation of the effect on corneal barrier function following wear of two contact lens&#xD;
      materials and two contact lens care systems, approved for marketing in the US by the Food and&#xD;
      Drug Administration. These contact lenses will be worn for two hours, following soak in one&#xD;
      of two marketed contact lens disinfecting solutions. Approximately 25 young, adapted contact&#xD;
      lens wearers will participate.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Epithelial penetration rate of sodium fluoeescein, in nm/sec</measure>
    <time_frame>Immediately post measurement</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Corneal staining</measure>
    <time_frame>Immediately following barrier determination</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Contact Lens Disinfecting Solutions</condition>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>contact lenses disinfected in multipurpose solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>contact lenses disinfected in multipurpose solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>contact lenses disinfected in multipurpose solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>contact lenses disinfected in multipurpose solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ProClear Lens Material soaked in ReNu Multiplus Multipurpose Solution</intervention_name>
    <description>Contact lens soaked in multipuprpose solution for 8 hours, then worn for two hours</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acuvue Advance Lens Material soaked in ReNu Multiplus Multipurpose Solution</intervention_name>
    <description>Contact lens soaked in multipuprpose solution for 8 hours, then worn for two hours</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acuvue Advance Lens Material soaked in Optifree RepleniSH Multipurpose Solution</intervention_name>
    <description>Contact lens soaked in multipuprpose solution for 8 hours, then worn for two hours</description>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ProClear Lens Material soaked in Optifree RepleniSH Multipurpose Solution</intervention_name>
    <description>Contact lens soaked in multipuprpose solution for 8 hours, then worn for two hours</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  At least 18 years of age.&#xD;
&#xD;
               -  Understand your rights as a research subject and give written informed consent by&#xD;
                  signing the Informed Consent Form, Subject Bill of Rights, and Patient&#xD;
                  Authorization for Use and Release of Health and Research Study Information (HIPAA&#xD;
                  form).&#xD;
&#xD;
               -  Be likely to finish the entire study, understand the study instructions, and be&#xD;
                  willing to follow the instructions.&#xD;
&#xD;
               -  Contact lens prescription between +4.00 D to -9.00 D (spherical equivalent).&#xD;
&#xD;
               -  Best correctable visual acuity of at least 20/40 in each eye.&#xD;
&#xD;
               -  Willing to de-adapt (do not wear) from habitual contact lenses for periods of&#xD;
                  three days prior to barrier function determination.&#xD;
&#xD;
               -  Possess a functional spectacle prescription to allow adequate vision during the&#xD;
                  de-adaptation and barrier function determination periods.&#xD;
&#xD;
               -  No known ocular or systemic allergies, which may interfere with contact lens&#xD;
                  wear.&#xD;
&#xD;
               -  No known systemic disease, or need for medication that may interfere with contact&#xD;
                  lens wear (i.e. antihistamines, beta-blockers, steroids).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects demonstrating any medical condition that may affect the results of this study&#xD;
             SHOULD NOT be enrolled. The following are specific conditions that exclude subjects&#xD;
             from enrollment in this study.&#xD;
&#xD;
               -  Eye (ocular) or systemic allergies that may interfere with contact lens wear.&#xD;
&#xD;
               -  Less than one month successful, full time (defined as more than 8 hours per day,&#xD;
                  and more than 5 days per week) soft lens wear.&#xD;
&#xD;
               -  Systemic disease or uses of medication, which may interfere with contact lens&#xD;
                  wear.&#xD;
&#xD;
               -  Clinically significant corneal swelling (greater than grade 3 or 4 on a 0-4&#xD;
                  scale), corneal blood vessel growth) (vascularization), corneal staining, bulbar&#xD;
                  redness, tarsal redness, or any other abnormality of the cornea that may cause&#xD;
                  unsafe contact lens wear.&#xD;
&#xD;
               -  Any active ocular infection.&#xD;
&#xD;
               -  Prior corneal refractive surgery (i.e., LASIK, PRK, etc).&#xD;
&#xD;
               -  Have used medications within 24 hours of study entry or have an ongoing need to&#xD;
                  use ocular medication.&#xD;
&#xD;
               -  Are taking part in any other study or have taken part in a study within the last&#xD;
                  14 days&#xD;
&#xD;
               -  Have a medical condition that your study eye doctor thinks may make it not&#xD;
                  appropriate for you to participate in this study.&#xD;
&#xD;
               -  Are pregnant, or anticipate becoming pregnant during the course of this study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jerry R Paugh, OD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Southern California College of Optometry at Marshall B. Ketchum University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Southern California College of Optometry</name>
      <address>
        <city>Fullerton</city>
        <state>California</state>
        <zip>92831</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <study_first_submitted>November 15, 2007</study_first_submitted>
  <study_first_submitted_qc>November 19, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2007</study_first_posted>
  <last_update_submitted>May 19, 2008</last_update_submitted>
  <last_update_submitted_qc>May 19, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 20, 2008</last_update_posted>
  <keyword>staining</keyword>
  <keyword>epithelial barrier function</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

